Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank21
3Y CAGR-18.9%
5Y CAGR-27.9%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-18.9%/yr
vs -5.5%/yr prior
5Y CAGR
-27.9%/yr
Recent acceleration
Acceleration
-13.3pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 9.57% |
| 2024 | 11.66% |
| 2023 | 10.51% |
| 2022 | 17.91% |
| 2021 | 22.06% |
| 2020 | 49.07% |
| 2019 | 36.59% |
| 2018 | 22.46% |
| 2017 | 46.20% |
| 2016 | 64.89% |